ClinicalTrials.Veeva

Menu
C

CNS Healthcare | Clinical Neuroscience Solutions - Memphis

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Methylphenidate
SPN-812
LDX
Testosterone
Cariprazine
SPN-810
Atogepant
CNP520
Loperamide
Sildenafil

Parent organization

This site is a part of CNS Healthcare

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 34 total trials

A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (FORTIFY)

The study consists of 4 sub-studies, as follows:* Sub-study 1 (Randomized, double-blind, placebo controlled study) to evaluate the efficacy and safet...

Active, not recruiting
Crohn's Disease
Drug: Placebo for Risankizumab IV
Drug: Risankizumab SC

Open label extension, long-term multicenter study of safety and efficacy of SPN-812 in pediatric ADHD patients

Active, not recruiting
Attention-Deficit/Hyperactivity Disorder
Drug: SPN-812

This is a Phase 3 Randomized Double-Blind Placebo-Controlled 1-year Parallel-Arm Study to Compare a Fixed Dose Combination of AD109 to Placebo in Obs...

Active, not recruiting
OSA
Drug: AD109
Drug: Placebo

Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and so...

Active, not recruiting
Episodic Migraine
Drug: Placebo
Drug: BOTOX

Trial sponsors

AbbVie logo
Supernus Pharmaceuticals logo
Allergan logo
Shire logo
Novartis logo
N
A
Apnimed logo
A
H

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems